XML 20 R9.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Cash flows from operating activities:              
Net earnings $ 599 $ 29 $ 1,755 $ 1,879 $ 628 $ 3,634  
Adjustments to reconcile net earnings to net cash provided (used) by operating activities:              
Change in receivables and advance premiums         (48) 19  
Capitalization of deferred policy acquisition costs         (503) (508)  
Amortization of deferred policy acquisition costs 221   208   437 424 $ 851
Increase in policy liabilities         (195) (43)  
Change in income tax liabilities         (267) (221)  
Net investment (gains) losses 421   (696)   1,384 (1,647)  
Other, net         (448) (554)  
Net cash provided (used) by operating activities         988 1,104  
Proceeds from investments sold or matured:              
Available-for-sale fixed maturity securities         7,816 3,598  
Equity securities         240 550  
Held-to-maturity fixed maturity securities         2 1  
Commercial mortgage and other loans         1,075 952  
Costs of investments acquired:              
Available-for-sale fixed maturity securities         (9,412) (3,357)  
Equity securities         (249) (179)  
Commercial mortgage and other loans         (799) (512)  
Other investments, net         (1,012) (2,284)  
Settlement of derivatives, net         26 (106)  
Cash received (pledged or returned) as collateral, net         3,523 3,375  
Other, net         (36) 256  
Net cash provided (used) by investing activities         1,174 2,294  
Cash flows from financing activities:              
Purchases of treasury stock         (1,729) (1,550)  
Proceeds from borrowings         1,039 823  
Principal payments under debt obligations         0 (194)  
Dividends paid to shareholders         (607) (550)  
Change in investment-type contracts, net         (123) (103)  
Treasury stock reissued         2 12  
Other, net         (5) (14)  
Net cash provided (used) by financing activities         (1,423) (1,576)  
Effect of exchange rate changes on cash and cash equivalents         (3) (68)  
Net change in cash and cash equivalents         736 1,754  
Cash and cash equivalents, beginning of period   $ 6,229   $ 4,306 6,229 4,306 4,306
Cash and cash equivalents, end of period $ 6,965   $ 6,060   6,965 6,060 $ 6,229
Supplemental disclosures of cash flow information:              
Income taxes paid         605 777  
Interest paid         92 87  
Noncash interest         10 11  
Noncash real estate acquired in satisfaction of debt         247 294  
Noncash financing activities:              
Lease obligations         19 20  
Associate stock bonus              
Treasury stock issued for:              
Treasury stock issued         12 10  
Shareholder dividend reinvestment              
Treasury stock issued for:              
Treasury stock issued         22 21  
Share-based compensation grants              
Treasury stock issued for:              
Treasury stock issued         $ 7 $ 6